In conversation with... Neerja Bhatla episode artwork

EPISODE · Nov 28, 2023 · 12 MIN

In conversation with... Neerja Bhatla

from Listen to The Lancet Oncology · host The Lancet

Professor Neerja Bhatla (All India Institute of Medical Sciences, New Delhi, India) discusses her Article on the Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India.

Episode metadata supplied by the publisher feed · Published Nov 28, 2023

Embed this episode

NOW PLAYING

In conversation with... Neerja Bhatla

0:00 12:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Oncology?

This episode is 12 minutes long.

When was this Listen to The Lancet Oncology episode published?

This episode was published on November 28, 2023.

Can I download this Listen to The Lancet Oncology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!